Skip to main content
. 2021 Feb 5;36(3):154–161. doi: 10.1097/YIC.0000000000000351

Table 4.

Treatment-emergent adverse events and overall tolerability

TEAEs throughout the study >2%, n (%)
 Total number of patients 46 (39.7)
  Akathisia 15 (12.9)
  Anxiety 12 (10.3)
  Parkinsonism 7 (6.0)
  Dizziness 4 (3.5)
  Lethargy 4 (3.5)
  Insomnia 3 (2.6)
  Sleep disorder 3 (2.6)
Physicians’ impression about overall tolerability, n (%)
 Very satisfied 52 (44.8)
 Satisfied 45 (38.8)
 Neutral 5 (4.3)
 Dissatisfied 12 (10.3)
 Very dissatisfied 2 (1.7)

TEAEs, treatment-emergent adverse events.